Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165737 · ClinicalTrials.gov registry record · Phase 3
Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
A Phase 3 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 3
- Development phase
- 974
- Enrollment target
NCT00165737: Completed Phase 3 study, sponsored by Eisai.
NCT00165737 is a Phase 3 study that has completed, run by Eisai. The registered enrollment target is 974 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (26% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165737, a Phase 3 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 974 participants
- Enrollment target
Study Summary
Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.
Interventions
- DRUG Donepezil Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 974 participants |
| Start Date | 2003-03 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
What the finished NCT00165737 record still lists
NCT00165737 is an interventional study that assigns participants to a tested intervention. The registered 974 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (26% higher).
The record links to 0 conditions, and to 1 intervention - of which Donepezil Hydrochloride is the first listed.
NCT00165737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00165737 about?
NCT00165737 is a clinical study titled "Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease". Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.
What is the current status of trial NCT00165737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 974 participants. The study started on 2003-03. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00165737?
The interventions under investigation include: Donepezil Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00165737?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00165737's enrollment target sits among peer trials
974 328th of 2000 higher than 1,672 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06948422 · 974 participants · Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NCT06820736 · 975 participants · NA
A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia